The lecture, titled "ESRA Coregulator Binding Site Inhibitors (ECBIs) as Novel Therapeutics for Treating Breast Cancer," will take place Sept. 8, 2016, at 4 p.m. in the first floor auditorium of the Medical Sciences Building on USA's main campus.
Dr. Vadlamudi earned both his master of science degree in food science and human nutrition and his Ph.D. in molecular biology from the University of Wyoming. His interests include characterizing the function of ER-coregulators in cancer progression and identifying novel molecular targets for therapeutic intervention.
The lecture series is comprised of distinguished scientists from other academic institutions who are invited by the USA College of Medicine basic science departments to present a seminar showcasing their latest research findings. Faculty, staff and students are strongly encouraged to attend.
